All News #Library
Janssen’s Imaavy Receives Approval In Europe
28 Nov 2025 //
EMA
Janssen-Cilag`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
18 Mar 2024 //
FDA
Janssen`s Biologic Tecvayli (teclistamab) Receives Approval in the U.S.
20 Feb 2024 //
FDA
Janssen`s Biologic Talvey (talquetamab-tgvs) Receives Approval in the U.S.
20 Feb 2024 //
FDA
Janssen-Cilag`s Talvey (talquetamab) Receives Approval in Europe
24 Nov 2023 //
EMA
Janssen-Cilag`s Biologic Rybrevant (Amivantamab) Receives Approval in Europe
01 Feb 2022 //
EMA

Market Place
Sourcing Support